Skip to main content
. 2021 Aug 17;20(1):91–104. doi: 10.1007/s40258-021-00675-z

Table 1.

Summary of previous economic models of interventions to reduce medication errors

First author and year Study population and setting Modelling method Categorisation of harm from errors Outcome measures
Karnon, (2008) [21] Inpatients of a 400-bed acute hospital in the UK Decision tree No harm, minor, moderate and severe/life-threatening harm

Incremental costs of correcting an error detected before administration, and treating the adverse effects of an error including extra tests, treatments and hospital length of stay

Monetary valuation of QoL reduction following a harmful error

Lahue, (2012) [2] Hospital inpatients receiving injectable medicines in the USA Not specifically named, but effectively a decision tree Harm and no harm Incremental cost of a harmful medication error
Samp, (2014) [22] Primary, secondary and tertiary care patients in the USA Decision tree 8 categories from combining: temporary, permanent or no harm; hospitalisation; treatment required; death Incremental costs of the error, including monitoring and those arising from permanent harm

QoL quality of life